6550 Share Price Performance
NT$30.10
-21.20 (-41.33%)
Price NT$30.10
Share Pricen/a
Polaris Group Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
6550 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Polaris Group Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -3.91
- -268.02%
- -4,250.74%
- 79.1%
About 6550
- Founded
- 2006
- Employees
- n/a
- CEO
- WebsiteView website
Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications, as well as provides healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Grand Cayman.
